Ad is loading...
RWBEX
Price
$66.90
Change
-$0.72 (-1.06%)
Updated
Nov 15 closing price
THOGX
Price
$38.44
Change
-$0.05 (-0.13%)
Updated
Nov 15 closing price
Ad is loading...

RWBEX vs THOGX

Header iconRWBEX vs THOGX Comparison
Open Charts RWBEX vs THOGXBanner chart's image
American Funds Capital World Gr&Inc R2E
Price$66.90
Change-$0.72 (-1.06%)
VolumeN/A
CapitalizationN/A
Thornburg Global Opportunities R6
Price$38.44
Change-$0.05 (-0.13%)
VolumeN/A
CapitalizationN/A
RWBEX vs THOGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWBEX vs. THOGX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWBEX is a Sell and THOGX is a Buy.

FUNDAMENTALS
Fundamentals
RWBEX has more cash in the bank: 125B vs. THOGX (1.22B). THOGX pays higher dividends than RWBEX: THOGX (2.04) vs RWBEX (1.28). RWBEX was incepted earlier than THOGX: RWBEX (10 years) vs THOGX (8 years). THOGX is a more actively managed with annual turnover of: 128.69 vs. RWBEX (27.00). THOGX has a lower initial minimum investment than RWBEX: THOGX (0) vs RWBEX (250). THOGX annual gain was more profitable for investors over the last year : 23.12 vs. RWBEX (18.55). RWBEX (37.10) and THOGX (36.07) have equivalent 5 years return.
RWBEXTHOGXRWBEX / THOGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years8 years-
Gain YTD12.64113.22596%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets125B1.22B10,212%
Annual Yield % from dividends1.282.0463%
Returns for 1 year18.5523.1280%
Returns for 3 years2.29-0.60-383%
Returns for 5 years37.1036.07103%
Returns for 10 years47.08N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EXTO3.91-0.02
-0.57%
Almacenes Exito SA
ARLP26.79-0.27
-1.00%
Alliance Resource Partners LP
DOCU79.11-1.25
-1.56%
DocuSign
RNAZ0.34-0.01
-2.92%
TransCode Therapeutics
PEPG4.12-0.37
-8.24%
PepGen